Welcome to the tag category page for Medical technology!
Sinus rhythm refers to the normal heartbeat rhythm that originates from the sinus node in the heart. It is characterized by a regular heartbeat with a rate of 60 to 100 bpm in adults. Sinus arrhythmia may also occur, which is an irregular rhythm with greater than 10% variation in the P-P interval. However, this type of arrhythmia is not dangerous and is a sign of a healthy heart. Normal sinus rhythm is associated with a regular ECG pattern, with normal P waves and ECG measurements. Overall, sinus rhythm is an important aspect of a healthy heart and its proper functioning.
Zelis is a company that specializes in modernizing the healthcare financial experience through data, insights, and solutions. They offer a connected platform that enables users to identify, optimize, and solve problems holistically. Zelis provides claims cost and payments optimization solutions to healthcare providers and payers. The company also offers medical billing software called Zelis Payments, which allows businesses to track sales data and accept payments in one place. Zelis is not a health insurance company, but they work with healthcare stakeholders to simplify the financial experience for all. Enrolling for ERAs with Zelis Payments is free and can be done online. David Zelis, MD, is a Pediatrics physician at WellSpan Pediatric Medicine - South Queen Street, York, PA, but it is unknown if he is related to Zelis, the company.
Semaglutide Injection is a medication used to treat type 2 diabetes and control blood sugar levels. It can also help lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. The medication is given once a week by injection under the skin of the thigh, stomach area, or upper arm. However, Semaglutide Injection comes with potential risks, such as an increased risk of developing tumors of the thyroid gland. Semaglutide Injection has also been shown to be effective in treating obesity and promoting weight loss. Studies have demonstrated weight loss of 6% to 12% within 12 to 28 weeks. While the medication may not provide immediate weight loss, it works quickly, with studies showing a reduction in body weight of over 2% within four weeks of taking Semaglutide Injection. The medication is relatively affordable, costing between $149 and $399 for a one-month supply depending on the dose. It is important for patients to consult with their healthcare provider about potential risks and benefits prior to use. Overall, Semaglutide Injection is a valuable tool in the treatment of type 2 diabetes and obesity.
Dulaglutide, also known as Trulicity, is a medication used to treat type 2 diabetes. It is a once-weekly injectable prescription medicine that improves blood sugar levels in adults with type 2 diabetes. Dulaglutide is used together with diet and exercise to control blood sugar. It is a subcutaneous glucagon-like peptide-1 (GLP-1) receptor agonist designed using recombinant DNA technology. It is similar to a natural hormone in the body known as incretin, and it works by causing insulin release in response to high blood sugar levels. Common side effects include nausea, diarrhea, vomiting, abdominal pain, decreased appetite, indigestion, and fatigue. Dulaglutide should only be used under the guidance and supervision of a healthcare provider.
